News

Deal Announcements

Divergence Receives $12 Million Series C Financing

Tuesday, February 17, 2009 5:58:00 AM PDT | VentureDeal Staff
St. Louis, Missouri  --  Biotechnology company Divergence has raised $11.8 million in its third round of institutional venture capital financing.

Divergence is working on technologies to control plant, animal and human parasitic nematodes.

MidPoint Food and Ag Fund was the lead investor in the round, which also included Prolog Ventures. Proceeds purposes from the funding round were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1